MedWatch

Novo Nordisk invests over USD 740m in Danish facility

The pharmaceutical firm is expanding its production facilities in Bagsværd, a Copenhagen suburb.

Photo: Stine Tidsvilde

Novo Nordisk plans to invest DKK 5.4bn (USD 744.4m) on expanding its existing facilities in Bagsværd, Greater Copenhagen, and construct a new building in extension of the existing site, the company writes in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs